Literature DB >> 30659009

Lithium neurotoxicity presenting as dementia with therapeutic serum lithium levels.

Sarita Soni1.   

Abstract

After 25 years of continuous lithium therapy, a woman with moderate intellectual disability and bipolar disorder developed symptoms suggestive of dementia. In fact, she had developed lithium neurotoxicity, but this was overlooked for 18 months as serial lithium levels were in the therapeutic range. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: psychiatry; mood disorders (including depression); psychiatry; psychiatry (drugs And Medicines); unwanted effects / adverse reactions

Mesh：

Substances：

Year:  2019        PMID： 30659009      PMCID： PMC6340573          DOI： 10.1136/bcr-2018-227741

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  17 in total

1.  Severe neurotoxicity associated with low-level serum lithium and risperidone after 25 years of uncomplicated lithium therapy.

Authors:  Rakesh Goyal; Yazman Ali
Journal:  J Clin Psychopharmacol       Date:  2014-10       Impact factor: 3.153

2.  Neurotoxicity with therapeutic lithium levels: a case report.

Authors:  Elizabeth C Grueneberger; E Maria Rountree; E Baron Short; David A Kahn
Journal:  J Psychiatr Pract       Date:  2009-01       Impact factor: 1.325

3.  Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology.

Authors:  C J Kemperman; J H Gerdes; J De Rooij; L M Vencken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

4.  A case with reversible neurotoxicity after 2 years of dementia secondary to maintenance lithium treatment.

Authors:  Juan Soriano-Barceló; María Tajes Alonso; María Begoña Portela Traba; Alberte Araúxo Vilar; David A Kahn
Journal:  J Psychiatr Pract       Date:  2015-03       Impact factor: 1.325

5.  Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder.

Authors:  A J Gelenberg; J M Kane; M B Keller; P Lavori; J F Rosenbaum; K Cole; J Lavelle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Lithium toxicity: an iatrogenic problem in susceptible individuals.

Authors:  P W Oakley; I M Whyte; G L Carter
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

7.  Reversible lithium neurotoxicity: review of the literatur.

Authors:  Ivan Netto; Vivek H Phutane
Journal:  Prim Care Companion CNS Disord       Date:  2012

Review 8.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 9.  The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review.

Authors:  S Deb; R Chaplin; S Sohanpal; G Unwin; R Soni; L Lenotre
Journal:  J Intellect Disabil Res       Date:  2008-02

10.  Case report on lithium intoxication with normal lithium levels.

Authors:  Jing Peng
Journal:  Shanghai Arch Psychiatry       Date:  2014-04
View more
  3 in total

1.  Lithium Intoxication as a cause of reversible dementia mimicking FDG PET features of Alzheimer's disease.

Authors:  Alexandre Motta Mecê; Vitor Corsaletti Abreu; Gustavo Manginelli Lamas; Rafaella do Rosário Tacla; Thais Benício Minekawa; Celso Dario Ramos; Marcio Luiz Figueiredo Balthazar
Journal:  Dement Neuropsychol       Date:  2022-04-29

2.  Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.

Authors:  Jussi Valtonen; Mira Karrasch
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28

3.  Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study.

Authors:  Shanquan Chen; Benjamin R Underwood; Peter B Jones; Jonathan R Lewis; Rudolf N Cardinal
Journal:  PLoS Med       Date:  2022-03-17       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.